Latest Advertising And Marketing News

Enero Group delivered stronger FY26 earnings and a $24.5 million net cash position, but its new financial year has opened with group EBITDA down 28% as Hotwire and BMF absorb restructuring and client losses. Orchard’s record quarter and rising AI revenue provide the counterweight, but execution remains the central test.

CONNEQT Health ended the September quarter with just A$501,000 in cash after a A$3.06 million operating outflow, equivalent to 0.16 quarters of funding at the reported burn rate. The company is pursuing R&D-backed debt, inventory finance and an equity raising as Pulse sales recover from an inventory disruption.

Proteomics International has begun the national rollout of its Promarker D and Promarker Eso blood tests through Healius, while a A$2 million tax incentive receipt has lifted pro forma cash to A$3.8 million. Promarker Endo also cleared an independent Oxford validation hurdle, but its commercial launch remains conditional.

EZZ Life Science cut its quarterly operating cash outflow sharply despite a 37.7% drop in customer receipts, as weaker Chinese e-commerce sales continued to weigh. EAORON skincare growth and a $9.16 million cash balance offer some support, but distributor collections and potential product returns remain unresolved.

I Synergy ended the September quarter with A$44,000 in cash and an estimated 0.76 quarters of funding, before securing A$200,000 in loan funding after quarter-end. Its proposed Macau digital economy partnership remains non-binding, while a prior half-year review flagged material uncertainty around going concern.

SportsHero says its rebuilt HeroPlay Gaming Universe is nearly ready for a November commercial launch after adding commerce, vouchers, payments and digital entertainment products. The expansion broadens the platform materially, but the next test is whether those capabilities translate into transaction revenue before cash burn becomes more pressing.

OMG Group has confirmed its first positive quarterly EBITDA, with Q1 FY27 sales rising 59% to approximately $1.92 million and gross profit growing faster than revenue. The result marks an earnings milestone, but operating cash flow remained negative as the company invested heavily in inventory and supplier deposits.

Hydralyte LLC recorded its first monthly operating profit in August, while a major cost reset cut its quarterly operating loss to US$66,900. But revenue fell 21.9%, cash narrowed to US$173,400 and the company is seeking up to A$1.4 million through a rights issue.

The Calmer Co. posted record Q1 FY27 revenue of A$2.44 million, powered by a sharp lift in US wholesale orders and continued Coles and Woolworths growth. But with A$953,000 in cash against quarterly operating outflows of A$755,000, the kava company remains dependent on further funding and sustained sales momentum.

Mustera Property Group has completed piling and erected the tower crane at its 42-apartment Verse on McCabe project, while the final Forbes Residences commercial lot has moved to an unconditional $2.4 million sale. The quarter also brought a $3.451 million operating cash outflow and $71.16 million in unused financing facilities.

ReNerve has reported its strongest quarter yet, with sales climbing to $584,000 as the medical device company expands across Asia-Pacific. The growth came alongside a secured funding drawdown, leaving the company with $1.62 million in cash but continued negative operating cash flow.

First Graphene reported unaudited first-quarter income of about A$201,000, up 21% year on year, as PureGRAPH moved into new cement, mining, composites and footwear applications. The commercial pipeline expanded, but A$915,000 of operating cash outflow left the company with A$1.831 million and an estimated two quarters of funding at the reported burn rate.